Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application

Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A 2016;113(8):E968-E77. Kowal, 2014, Biogenesis and secretion of exosomes, Curr Opin Cell Biol, 29, 116, 10.1016/j.ceb.2014.05.004 Alipoor, 2016, Exosomes and Exosomal miRNA in respiratory diseases %J, Mediators Inflamm, 2016, 11, 10.1155/2016/5628404 Balaj L, Lessard R, Dai L, Cho Y-J, Pomeroy SL, Breakefield XO, et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun2:180-. Kalluri, 2016, The biology and function of exosomes in cancer, J Clin Invest, 126, 1208, 10.1172/JCI81135 Thakur, 2014, Double-stranded DNA in exosomes: a novel biomarker in cancer detection, Cell Res, 24, 766, 10.1038/cr.2014.44 Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat Cell Biol, 9, 654, 10.1038/ncb1596 Bobrie A, Colombo M, Raposo G, Théry C. Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses. 2011;12(12):1659–68. Mittelbrunn, 2011, Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells, Nat Commun, 2, 282, 10.1038/ncomms1285 Johnstone, 1987, Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes), J Biol Chem, 262, 9412, 10.1016/S0021-9258(18)48095-7 Cossetti, 2014, Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells, Mol Cell, 56, 193, 10.1016/j.molcel.2014.08.020 Gangoda, 2015, Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?, Proteomics, 15, 260, 10.1002/pmic.201400234 Syn, 2016, Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance, Trends Pharmacol Sci, 37, 606, 10.1016/j.tips.2016.04.006 Zhang, 2015, Exosomes in cancer: small particle, big player, J Hematol Oncol, 8, 83, 10.1186/s13045-015-0181-x Yu, 2007, Tumor exosomes inhibit differentiation of bone marrow dendritic cells, The Journal of Immunology, 178, 6867, 10.4049/jimmunol.178.11.6867 Arbab, 1996, A revised method of labeling mouse IgG with yttrium-90, Yamanashi Ika Daigaku Zasshi, 10, 121 Borin, 2017, HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model, PLoS One, 12, e0178830, 10.1371/journal.pone.0178830 Borin, 2017, CSF1R inhibitor prevented pre-metastatic lung niches in metastatic mammary tumor, Cancer Res, 1043, 10.1158/1538-7445.AM2017-1043 Angara, 2016, Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies, Histol Histopathol, 19, 11856 Jain, 2017, Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models, Sci Rep Borin, 2019, Abstract 127: CYP4A11 overexpression increases aggressiveness in glioblastoma and breast cancer, Cancer Res, 127, 10.1158/1538-7445.AM2019-127 Chen, 2017, CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis, Oncogene, 36, 5045, 10.1038/onc.2017.118 Li, 2017, Progress in exosome isolation techniques, Theranostics, 7, 789, 10.7150/thno.18133 Bellavia, 2017, Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth, Theranostics., 7, 1333, 10.7150/thno.17092 Hoshino, 2015, Tumour exosome integrins determine organotropic metastasis, Nature, 527, 329, 10.1038/nature15756 S-i, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Molecular therapy : the journal of the American Society of Gene Therapy, 21, 185, 10.1038/mt.2012.180 Smyth, 2015, Biodistribution and delivery efficiency of unmodified tumor-derived exosomes, J Control Release, 199, 145, 10.1016/j.jconrel.2014.12.013 Watson, 2016, Efficient production and enhanced tumor delivery of engineered extracellular vesicles, Biomaterials, 105, 195, 10.1016/j.biomaterials.2016.07.003 Lai, 2014, Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter, ACS Nano, 8, 483, 10.1021/nn404945r Gangadaran, 2018, An update on in vivo imaging of extracellular vesicles as drug delivery vehicles, Front Pharmacol, 9 Ahn, 2012, Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back, Theranostics., 2, 392, 10.7150/thno.3722 Kogai T, Taki K, Brent GA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. 2006;13(3):797. Baril, 2010, Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy, Br J Pharmacol, 159, 761, 10.1111/j.1476-5381.2009.00412.x Condamine T, Ramachandran I, Youn J-I, Gabrilovich DI. Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells. 2015;66(1):97–110. Solito, 2017, In brief: myeloid-derived suppressor cells in cancer, J Pathol, 242, 7, 10.1002/path.4876 Burke, 2014, Exosomes from myeloid-derived suppressor cells carry biologically active proteins, J Proteome Res, 13, 836, 10.1021/pr400879c Deng, 2016, Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis, Oncogene, 36, 639, 10.1038/onc.2016.229 Wang, 2016, Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice, Oncotarget, 7, 15356, 10.18632/oncotarget.7324 Zöller, 2018, 9, 137 Han, 2016, Exosomes and their therapeutic potentials of stem cells %J, Stem Cells International, 2016, 11, 10.1155/2016/7653489 Wu, 2018, Exosomes derived from endothelial progenitor cells ameliorate acute lung injury by transferring miR-126, Exp Cell Res, 370, 13, 10.1016/j.yexcr.2018.06.003 Zhang, 2016, Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling, Int J Biol Sci, 12, 1472, 10.7150/ijbs.15514 Farshad Nassiri, 2011, Endoglin (Cd105): A Review Of Its role in angiogenesis and tumor diagnosis, progression and therapy, Anticancer Res, 31, 2283 Shibuya, 2011, Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-Angiogenic therapies, Genes Cancer, 2, 1097, 10.1177/1947601911423031 Kevil, 2004, Intercellular adhesion Molecule-1 (ICAM-1) regulates endothelial cell motility through a nitric oxide-dependent pathway, J Biol Chem, 279, 19230, 10.1074/jbc.M312025200 Murakami, 2008, The FGF system has a key role in regulating vascular integrity, J Clin Invest, 118, 3355, 10.1172/JCI35298 Ouzounova, 2017, Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade, Nat Commun, 8, 10.1038/ncomms14979 Uemura, 2006, Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways, Int J Mol Med, 18, 365 Allavena, 2008, The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages, Crit Rev Oncol Hematol, 66, 1, 10.1016/j.critrevonc.2007.07.004 Esquivel-Velázquez, 2015, The role of cytokines in breast cancer development and progression, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 35, 1, 10.1089/jir.2014.0026 Wang, 2017, CXCL1 is critical for Premetastatic niche formation and metastasis in colorectal Cancer, Cancer Res, 77, 3655, 10.1158/0008-5472.CAN-16-3199 Yuan, 2016, Tumor-derived CXCL1 promotes lung Cancer growth via recruitment of tumor-associated neutrophils, J Immunol Res, 2016, 10.1155/2016/6530410 Kumari, 2016, Role of interleukin-6 in cancer progression and therapeutic resistance, Tumor Biology, 37, 11553, 10.1007/s13277-016-5098-7 Hannun, 1997, Apoptosis and the dilemma of Cancer chemotherapy, Blood, 89, 1845, 10.1182/blood.V89.6.1845 Igney, 2005, Tumor counterattack: fact or fiction?, Cancer Immunol Immunother, 54, 1127, 10.1007/s00262-005-0680-7